The monoclonal antibody cocktail treatment has picked up in India after Roche India received the emergency use authorisation (EUA) for importing the globally manufactured product last month. The neutralising antibody cocktail was successfully administered to former US president Donald Trump and has found positive results in Indian patients, too. Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease. Here’s what we know about this therapy, which is still in early stages:
What is a monoclonal antibody cocktail?
It is a combination of two types of genetically